Carp H, Janoff A
J Clin Invest. 1979 Apr;63(4):793-7. doi: 10.1172/JCI109364.
Human polymorphonuclear leukocytes (PMN) phagocytosing opsonized antigen-antibody complexes, produce dialyzable species of activated oxygen which are capable of partially suppressing the elastase-inhibiting capacity (EIC) of whole human serum or purified human alpha1-proteinase inhibitor. Serum EIC was partially protially protected by superoxide dismutase, catalase, or mannitol, suggesting that hydroxyl radical, formed by interaction of superoxide radical and hydrogen peroxide, might be responsible for this effect. NaN3 also partly protected EIC, implicating myeloperoxidase-mediated reactions as well. An artificial superoxide rradical-generating system, involving xanthine and xanthine-oxidase, could be substituted for phagocytosing PMN with resultant EIC suppression. These results are consistent with previous demonstrations of the release of potent oxidants by stimulated PMN, as well as earlier studies from our laboratory showing sensitivity of alpha1-proteinase inhibitor to inactivation by oxidants. Oxidative inactivation of proteinase inhibitors in the microenvironment of PMN accumulating at sites of inflammation may allow proteases released from these cells to more readily damage adjacent connective tissue structures.
人类多形核白细胞(PMN)吞噬调理素化的抗原 - 抗体复合物后,会产生可透析的活性氧种类,这些活性氧能够部分抑制全人血清或纯化的人α1 - 蛋白酶抑制剂的弹性蛋白酶抑制能力(EIC)。血清EIC受到超氧化物歧化酶、过氧化氢酶或甘露醇的部分保护,这表明超氧阴离子与过氧化氢相互作用形成的羟基自由基可能是造成这种效应的原因。NaN3也能部分保护EIC,这也表明髓过氧化物酶介导的反应也参与其中。一个涉及黄嘌呤和黄嘌呤氧化酶的人工超氧阴离子生成系统,可以替代吞噬性PMN,导致EIC受到抑制。这些结果与之前关于受刺激的PMN释放强效氧化剂的证明一致,也与我们实验室早期的研究结果相符,即α1 - 蛋白酶抑制剂对氧化剂灭活敏感。在炎症部位聚集的PMN微环境中,蛋白酶抑制剂的氧化失活可能会使这些细胞释放的蛋白酶更容易损伤相邻的结缔组织结构。